Boehringer Ingelheim and Alpha Pharma Collaborate to localize the production of one of its Type 2 Diabetes Medicines in Saudi Arabia

Boehringer Ingelheim and Alpha Pharma Collaborate to localize the production of one of its Type 2 Diabetes Medicines in Saudi Arabia

Under the patronage of the Local Content and Government Procurement Authority, Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced today the successful transfer of manufacturing operations of one of its innovative medicines for the treatment of type 2 diabetes to Alpha Pharma in Saudi Arabia. This announcement follows Boehringer’s 2023 Memorandum of Boehringer Ingelheim and Alpha Pharma Collaborate to localize the production of one of its Type 2 Diabetes Medicines in Saudi Arabia